Ritoncology.com

Ritoncology.com has Server used 141.8.225.31 IP Address with Hostname in Switzerland. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2008-10-26 (10 years, 268 days) and hosted in Switzerland, server ping response time 93 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Ritoncology keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Rit oncology llc
2 Rat oncology models
3 Ret oncology
4 Ret oncology fish

Hosting Provider

Website: Ritoncology.com
Hostname: 141.8.225.31
Country:
Latitude: 47.144901275635
Longitude: 8.1550998687744
Area Code: 0
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   Aaimpact.com (31 seconds ago)

   Intimaa.com (7 seconds ago)

   Turbocache.com (5 seconds ago)

   Madrak20.com (9 seconds ago)

   Nple.com (6 seconds ago)

   Unimix-uae.com (7 seconds ago)

   Duongquoccuongbds.com (27 seconds ago)

   Carpenterplace.org (4 seconds ago)

   Rkmsargachi.org (1 seconds ago)

   Thornhill-dillon.com (7 seconds ago)

   Kwcfl.org (10 seconds ago)

   Theirvingprocessserver.com (3 seconds ago)

   Ritoncology.com (0 seconds ago)

   Fatefortune.org (22 seconds ago)

   Redhunttravel.com (5 seconds ago)

   Cappafe.com (14 seconds ago)

   Gulfcoastbaptist.org (18 seconds ago)

   Mkrlegal.com (12 seconds ago)

   Only40.com (8 seconds ago)

Results For Websites Listing

Found 41 Websites with content related to this domain, It is result after search with search engine

RIT Oncology, LLC: Private Company Information - Bloomberg

RIT Oncology, LLC engages in commercialization and development of cancer drug Zevalin, cancer therapy called radioimmunotherapy. The company is based in Seattle, Washington. As of March 15, 2009

https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=51276121

RIT Oncology Company Profile: Acquisition & Investors

Information on acquisition, funding, investments, investors, and executives for RIT Oncology. Use the PitchBook Platform to explore the full profile.

https://pitchbook.com/profiles/company/122899-78

Rit Oncology Llc in Seattle, WA with Reviews - YP.com

Find 692 listings related to Rit Oncology Llc in Seattle on YP.com. See reviews, photos, directions, phone numbers and more for Rit Oncology Llc locations in Seattle, WA.

https://www.yellowpages.com/seattle-wa/rit-oncology-llc?page=4

Indium In 111 - FDA prescribing information, side effects

Indium In 111 - Clinical Pharmacology. Please refer to the package insert for ProstaScint or Zevalin for this information on the final drug product. Indications and Usage for Indium In 111. Indium In 111 Chloride Sterile Solution is indicated for radiolabeling ProstaScint preparations used for in vivo diagnostic imaging procedures.

https://www.drugs.com/pro/indium-in-111.html

RIT Oncology LLC - Scrip

RIT Oncology LLC Email Company All set! This article has been sent to [email protected] All fields are required. For multiple recipients, separate email addresses with a semicolon. Please make sure all fields are completed. Please enter a valid e-mail address Please make sure you have filled out all fields

https://scrip.pharmaintelligence.informa.com/companies/200800694

ritoncology.com is down. - Is My Website Online?

Monitor the status of your favorite web sites and checks whether they are down or not. Just enter the url and status test will be perfomed on the domain name in real time.

https://www.ismywebsiteonline.com/ritoncology.com

Next generation of radio immunotherapy (RIT) | OncologyPRO

Practice Tools. ESMO has developed a set of organ-specific tools designed to assist oncologists in their daily practice. ESMO How To videos: A series of educational videos with recognised experts aiming to assist oncologists in their daily practice and support clinical decision making in oncology. 'How To' know when a re-biopsy is necessary for an advanced NSCLC patient?, by Solange Peters

https://oncologypro.esmo.org/Meeting-Resources/TAT-2018-Targeted-Anticancer-Therapies/Next-generation-of-radio-immunotherapy-RIT

Spectrum Pharmaceuticals Acquires 100% of ZEVALIN, an FDA

Spectrum Pharmaceuticals, Inc. Acquires 100% of ZEVALIN, an FDA-Approved, Proprietary, Biological Drug for Non-Hodgkin's Lymphoma March 16, 2009 IRVINE, Calif.--(BUSINESS WIRE)--Spectrum

https://www.fiercebiotech.com/biotech/spectrum-pharmaceuticals-acquires-100-of-zevalin-an-fda-approved-proprietary-biological

Spectrum Pharmaceuticals Forms JV with Cell Therapeutics

Upon formation of RIT Oncology, Cell Therapeutics will receive $7.5M, another $7.5M in January, and up to $15M later in milestones. Spectrum Pharmaceuticals and Cell Therapeutics (CTI) will form a

https://www.genengnews.com/news/spectrum-pharmaceuticals-forms-jv-with-cell-therapeutics-to-jointly-market-oncology-drug-2/

Spectrum Pharmaceuticals and Cell Therapeutics Close

Spectrum Pharmaceuticals and Cell Therapeutics Close Transaction to Market ZEVALIN® by Forming RIT Oncology LLC, a Joint Venture IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals

https://www.fiercebiotech.com/biotech/spectrum-pharmaceuticals-and-cell-therapeutics-close-transaction-to-market-zevalinâ®-by

Recently Analyzed Sites